
Post-MPN AML: Real-World Outcomes and Ongoing Challenges
Have newer therapies improved outcomes for patients with acute myeloid leukemia after myeloproliferative neoplasms, or post-MPN AML? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Cour





